SHH · 600351.SS
Yabao Pharmaceutical Group Co., Ltd
CN¥7.18CN¥0.00 (0.0%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
Loading market information…
SHH · 600479.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s forward annual dividend is CN¥0.72 per share, paid quarterly. The forward yield is 6.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ZhuZhou QianJin Pharmaceutical Co.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1993 and headquartered in Zhuzhou, China, ZhuZhou QianJin Pharmaceutical Co.,Ltd operates as a leading manufacturer and distributor of pharmaceutical goods throughout China. The company boasts a comprehensive product portfolio, encompassing treatments for women's health, pediatric ailments, dermatological concerns, anti-infectives, and conditions affecting the circulatory, endocrine, digestive, nervous, and cardiovascular systems. Additionally, they offer specialized medications and traditional Chinese remedies. These diverse pharmaceutical offerings are presented in various formats, including pills, tablets, capsules, granules, powders, decoctions, and liquid solutions. Beyond its core pharmaceutical business, ZhuZhou QianJin also produces ginger-based beverages, feminine hygiene products, and alcoholic beverages.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥7.18CN¥0.00 (0.0%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
CN¥10.04CN¥0.00 (0.0%)
Hunan Fangsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.63% below the high.
CN¥4.59CN¥0.00 (0.0%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.43% below the high.
CN¥8.29CN¥0.00 (0.0%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
